Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study.
Nagahara A, Uemura M, Sato M, Nakata W, Tsujihata M, Takao T, Matsumura S, Nishimura K, Takada S, Iwanishi T, Kobayashi Y, Ishizuya Y, Takada T, Okada K, Inoue H, Kato T, Hatano K, Kawashima A, Ujike T, Fujita K, Nonomura N.
Nagahara A, et al. Among authors: fujita k.
Jpn J Clin Oncol. 2024 May 7;54(5):584-591. doi: 10.1093/jjco/hyae004.
Jpn J Clin Oncol. 2024.
PMID: 38305451
Free PMC article.